Evidence map›Paper›PMID 27215922›Full record

ArticleThe American journal of gastroenterology2016

Measurement of Inflammation in Eosinophilic Esophagitis Using an Eosinophil Peroxidase Assay.

Hedieh Saffari, Kristin M Leiferman, Frederic Clayton, Krista Baer, Leonard F Iii Pease, Gerald J Gleich, Kathryn A Peterson

Abstract read
PubMed Publisher
In one paragraph

Article in The American journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Eosinophils and eosinophil-associated diseases: An update.The Journal of allergy and clinical immunology · 2018
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Non-invasive biomarkers of eosinophilic esophagitis.Acta bio-medica : Atenei Parmensis · 2021
    Review
  11. Article
  12. Pathophysiology of Eosinophilic Esophagitis.Clinical reviews in allergy & immunology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hedieh SaffariDepartment of Dermatology, University of Utah, Salt Lake City, Utah, USA.
Kristin M LeifermanDepartment of Dermatology, University of Utah, Salt Lake City, Utah, USA.
Frederic ClaytonDepartment of Pathology, University of Utah, Salt Lake City, Utah, USA.
Krista BaerDepartment of Internal Medicine, Division of Gastroenterology, University of Utah, Salt Lake City, Utah, USA.
Leonard F Iii PeaseDepartment of Internal Medicine, Division of Gastroenterology, University of Utah, Salt Lake City, Utah, USA.
Gerald J GleichDepartment of Dermatology, University of Utah, Salt Lake City, Utah, USA.
Kathryn A PetersonDepartment of Internal Medicine, Division of Gastroenterology, University of Utah, Salt Lake City, Utah, USA.
University of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe describe a simple, quick method to measure an eosinophil granule protein, eosinophil peroxidase (EPO), as a marker of eosinophil activity, in eosinophilic esophagitis (EoE).

methodsEsophageal mucosal brushings initially were collected from 36 patients with active EoE (n=13), resolved EoE (n=13), and controls (n=10) before endoscopic biopsy collection; the brushes were frozen at -80 ºC until assayed. EPO on the brush was measured in a colorimetric assay visually and by spectrophotometric absorbance measurements (at 492 nm), and was compared with peak eosinophil counts in esophageal biopsy specimens. The assay was calibrated with known EPO concentrations; as EPO increased in the assay, the color changed from light yellow to dark brown.

resultsMucosal brush specimens from active EoE yielded orange to dark brown colors with absorbance measurements > 1.1 U; in contrast, control and resolved EoE brush specimens yielded a light to dark yellow color with absorbance measurements < 1.1. We then corroborated the results at the bedside (real time) in 16 additional patients. EPO on the brush was measured directly in < 1 h in the assay visually and by absorbance at 492 nm. Absorbance units strongly correlated with peak eosinophil counts both with the frozen brush (rs=0.79, P<0.0001) and with the bedside (rs=0.86, P<0.00017) approaches.

conclusionsThe results support the use of this rapid method to detect and monitor EoE disease activity. Moreover, because eosinophils infiltrate and degranulate in the esophagus in EoE in a patchy manner, this method may be more accurate than current practice by testing for an eosinophil constituent from both intact and degranulated cells, and by sampling large portions of the esophageal lumen rather than small biopsy specimens that may not be representative of eosinophil involvement.

Indexed as

Eosinophilic EsophagitisEsophageal MucosaInflammationAdultBiomarkersBiopsyComparative Effectiveness ResearchEndoscopyEnzyme AssaysEosinophil PeroxidaseFemaleHumansMaleMiddle AgedPatient AcuityReproducibility of ResultsBiomarkersEosinophil Peroxidase

Identifiers

PMID27215922
OpenAlexW2403189010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.